KCM
PRAX icon

Kennedy Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Kennedy Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-76,218
Closed -$4.04M – 581
2025
Q3 		$4.04M Buy
76,218
+5,773
+8% +$280K 0.09% 328
2025
Q2 		$2.96M Buy
70,445
+5,180
+8% +$197K 0.07% 374
2025
Q1 		$2.47M Buy
+65,265
New +$4.08M 0.06% 405

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Kennedy Capital Management's PRAX Position: Q4 2025 in Review

Kennedy Capital Management sold out of Praxis Precision Medicines (PRAX) in Q4 2025, closing a stake of 76,218 shares — an estimated $4.04M sold.

Kennedy Capital Management first reported a position in PRAX in Q1 2025 and held it in 3 quarters. The position peaked at $4.04M in Q3 2025. 250 funds tracked by Wall St. Rank hold PRAX as of Q4 2025.

  • Kennedy Capital Management reported no remaining Praxis Precision Medicines position as of Q4 2025 after selling out during the quarter.
  • Kennedy Capital Management sold 76,218 Praxis Precision Medicines shares in Q4 2025, an estimated $4.04M.
  • Kennedy Capital Management first reported a position in Praxis Precision Medicines in Q1 2025 and held it in 3 quarters.
  • Kennedy Capital Management's Praxis Precision Medicines position peaked at $4.04M in Q3 2025.
  • 250 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q4 2025.

Based on Kennedy Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.